Establishes "End-Stage Kidney Disease Prevention and Innovation Act"; appropriates $10 million.

This bill creates the "End-Stage Kidney Disease Prevention and Innovation Act" to establish research centers focused on rare kidney diseases within New Jersey's Department of Health. The legislation allocates $10 million to fund grants and cooperative agreements with public and private nonprofit organizations, prioritizing institutions that serve minority and underserved communities. Key provisions include conducting research on disease causes and treatments, increasing public awareness, offering fellowships for nephrology training, and ensuring that studies do not use metrics that discriminate against individuals with disabilities. Additionally, the bill mandates a study on testing methods and preventative care, with specific attention to genetic testing for the APOL1 gene and its impact on diagnosis and treatment.